Skip to main content
Abbisko Cayman Limited logo

Abbisko Cayman Limited — Investor Relations & Filings

Ticker · 2256 ISIN · KYG0028A1085 LEI · 655600UAX2YV03PRXN31 HKEX Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2026-05-20 Governance Information
Country KY Cayman Islands
Listing HKEX 2256

About Abbisko Cayman Limited

http://www.abbisko.com

Abbisko Cayman Limited is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule therapies. The company leverages a robust in-house R&D engine and a multi-dimensional discovery platform to advance a rich pipeline focused primarily on oncology, encompassing both precision-oncology and immuno-oncology candidates. Key product candidates include pimicotinib, which has shown positive topline results for the treatment of tenosynovial giant cell tumor (TGCT). Abbisko aims to develop novel treatments that address critical unmet medical needs for patients globally.

Recent filings

Filing Released Lang Actions
ELEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 93% confidence The document is the Eleventh Amended and Restated Memorandum and Articles of Association of Abbisko Cayman Limited, which sets out the company’s constitutional governance framework, internal rules, share capital provisions, board and meeting procedures, and other corporate governance articles. This is not an announcement of a report, not financial statements, nor management changes or voting results. It is a governance charter, so it falls under Governance Information (CGR).
2026-05-20 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 20, 2026 AND AMENDMENTS TO THE ARTICLES
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an official announcement of the poll results at the company’s Annual General Meeting (AGM) held on May 20, 2026, detailing vote counts on ordinary and special resolutions and amendments to the articles of association. It does not contain the AGM materials themselves, nor full financial statements or management discussion. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-06 English
Next Day Disclosure Returns
Share Issue/Capital Change Classification · 92% confidence The document is the Hong Kong Exchange “Next Day Disclosure Return” FF305, detailing changes in issued shares (new placing under general mandate) and treasury shares (repurchases for cancellation). This is a mandatory stock exchange disclosure of share capital changes under Main Board Rule 13.25A/GEM Rule 17.27A, covering new share issues and share repurchases. It therefore falls under the “Share Issue/Capital Change” category.
2026-04-28 English
COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE
Share Issue/Capital Change Classification · 94% confidence The document is an official announcement by Abbisko Cayman Limited regarding the completion of a placing of 42,900,000 new shares under the company’s general mandate. It provides details of the number of shares issued, placing price, use of proceeds, and effects on shareholding structure—all hallmarks of a share issue notice. As it specifically relates to the issuance of new shares (rather than broader fundraising commentary), it fits the definition of Share Issue/Capital Change (Code: SHA).
2026-04-28 English
Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 80% confidence The document is a reminder letter to non-registered shareholders about the arrangement for electronic dissemination of corporate communications (annual reports, interim reports, notices, circulars, proxy forms, etc.) and how to opt for printed copies. It is neither an actual annual/interim report nor a notice of dividend, board change, financing, nor a Q&A transcript; rather it is a regulatory announcement to shareholders about communication procedures. No specific financial data or voting matters are presented. Therefore it best fits the catch-all “Regulatory Filings” category.
2026-04-28 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.